During a major symposium hosted by the Cure Alzheimer's Fund at the Boston Public Library on Wednesday, Oct. 19, three leading Alzheimer’s researchers discussed recent findings for how to slow and prevent the disease.
"Cure Alzheimer's Fund is pleased to be working with those on the cutting edge of Alzheimer's research," Tim Armour, president and CEO of the nonprofit, said. "Over the past few years, the medical community has made some important discoveries, which are bringing us closer to finding effective treatments for the disease. The symposium is a way for those researchers to share their knowledge with the public."
Researchers speaking at the symposium were Duke University's Dr. Murali Doraiswamy, Dr. Beth Stevens of Boston Children’s Hospital and Dr. Rudy Tanzi of Massachusetts General Hospital. Doraiswamy studies sex-based differences in the disease, because women are twice as likely to be inflicted. Stevens researches the role microglia plays in synapse loss. Tanzi researches the complex pathology of Alzheimer’s disease.
"It is an exciting time for those researching Alzheimer's disease," Tanzi said. "Over the past several years, we've learned a considerable amount about how the brain functions and how the disease is formed. As we learn more about Alzheimer's, we are also exploring new possibilities in both prevention and treatment. Cure Alzheimer's Fund is an important part of these discoveries, as the organization provides crucial early stage funding for so many researchers."
